Ovarian vein thrombosis is an uncommon but potentially serious disorder that is associated with a variety of pelvic conditions?most notably, recent childbirth. It could also be associated with pelvic inflammatory disease, malignancies, and pelvic surgery. Ovarian vein thrombosis occurs in 0.05?0.18% of pregnancies and is diagnosed on the right side in 80?90% of the affected postpartum patients [¹?³]. Prompt diagnosis and treatment of this condition is needed to avoid the morbidity and mortality that are related both to the thrombosis and to any associated infection/sepsis. One of these cases illustrates the importance of including ovarian vein thrombosis as a differential diagnosis in women who present in the postpartum period with a tender pelvic mass.

Women are five times more likely to suffer from a thromboembolic event when they are pregnant1. The overall incidence of thromboembolic events ranges from 0.3% to 1.2% [²]. The most common postpartum thromboembolic events include deep vein thrombosis and pulmonary emboli. However, ovarian vein thrombosis complicates 0.05%?0.18% of pregnancies [³?⁵].

The first case of postpartum ovarian vein thrombosis was described by Austin in 1956 [⁶]. The pathophysiology of ovarian vein thrombosis is ascribed to Virchow's triad of hypercoagulability, venous stasis, and endothelial trauma. Pregnancy is a period where women are at a hypercoagulable state due to normal physiological changes. These changes include an increase in clotting factors such as factors VII, VIII, IX, X, XII, vWF, and fibrinogen. As well, free levels of protein S are decreased. There is venous stasis of the lower limbs due to compression of the pelvic veins and inferior vena cava by the uterus. Increased levels of estrogen and increased local production of nitric oxide and prostacyclin also contribute to increased deep vein capacitance.

Endothelial trauma can occur at the time delivery or from local inflammation. These pregnancy-induced changes help protect women from hemorrhagic complications during placentation and labour; however, they also place women at an increased risk of venous thromboembolic diseases.

The right ovarian vein is implicated in 90% of cases of ovarian vein thrombosis [³]. Several explanations have been proposed for this skew towards the right ovarian vein ranging from retrograde drainage from the left ovarian vein and anterograde flow into the right ovarian vein in the postpartum setting to dextrorotation of the enlarging uterus, causing compression of the right ovarian vein and right ureter as they cross the pelvic brim and the fact that the right ovarian vein is longer than the left, and when dilated, the valves become incompetent, making it easier for a thrombus to form [², ³, ⁷, ⁸].

Patients with ovarian vein thrombosis typically present with fever, pelvic pain, and a ?ropelike? palpable abdominal mass [⁵, ⁹]. Case 2, however, did not present with fever, but she gave a history of being feverish few days prior to her second admission. We, however, decided to treat her with antibiotics despite her lack of any evidence of fever. We do not understand the reason for air in her uterus but we were very suspicious of endometritis hence we considered to treat her with antibiotics. Case 1, however, was discharged prematurely with the followup to be conducted by her family physician. This patient should have been kept for few more days in hindsight. The incidence peaks around postpartum day 2 for full-term deliveries and occurs within 10 days postpartum in 90% of cases [⁹]. As symptoms are nonspecific, the diagnosis of ovarian vein thrombosis may be delayed. The differential diagnosis for ovarian vein thrombosis includes appendicitis, endometritis, adnexal torsion, pyelonephritis, and septic pelvic thrombophlebitis. Ovarian vein thrombosis is differentiated clinically from septic thrombophlebitis in that patients with septic thrombophlebitis appear clinically well but have continuing high spiking fevers, but the physical examination is also normal [³].

The diagnosis of ovarian vein thrombosis is ideally made with pelvic CT scanning, which will show an enlarged vein with a low-density lumen and sharply defined walls [⁹, ¹⁰]. However, ultrasound is commonly used as the first radiographic investigation in postpartum women. Ultrasound scan in Case 2 was not conclusive, but the computed tomogram enabled us to make a definitive diagnosis. Ovarian vein thrombosis on ultrasound will appear as an anechoic to hypoechoic mass between the adnexa and the inferior vena cava, with absence of blood flow [³]. The sensitivity of CT scanning for diagnosing ovarian vein thrombosis is 100%, and 52% for Doppler ultrasonography [²]. Magnetic resonance image is considered ideal for its sensitivity and lack of ionizing radiation.

Treatment for ovarian vein thrombosis includes antibiotics and anticoagulation. Appropriate antibiotics include clindamycin, or gentamicin, or a second- or third-generation cephalosporin. Although low-molecular-weight heparins have been shown to be as effective as unfractionated heparin for treating ovarian vein thrombosis, the studies providing this evidence are of small design with unsatisfactory data. Further investigation is required to determine if low-molecular-weight heparins are appropriate to use in treatment of ovarian vein thrombosis [³, ⁹]. We were quite concerned about the size of the thrombosed ovarian vein in Case 2 despite that, without any evidence of fever, she was given Cefazolin to which she responded quite well.

Complications of ovarian vein thrombosis include sepsis, thrombus extending to the inferior vena cava and renal veins, and pulmonary embolism. The incidence of pulmonary embolism is reported to be 13.2% [⁵]. These complications can be managed surgically with thrombectomy or with an inferior vena cava filter. Mortality due to ovarian vein thrombosis is less than 5%, most cases of which are due to pulmonary embolism [³]. Some degree of morbidity could be encountered in cases inappropriately and promptly managed.

Ovarian vein thrombosis, rare as it, could present late in postpartum women with serious consequences, hence a high index of suspicion for diagnosis and management is required to avoid an associated mortality and morbidity. There was no mortality in these two patients, but morbidity was reduced with prompt diagnosis and appropriate treatment.

This report involved no sources of funding for any of the authors. Written informed consent was obtained from the patient for publication of this case and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. The authors declare that they have no competing interests. A. A. Akinbiyi, R. Nguyen, and M. Katz were all involved in the drafting and re-editing of the manuscript. The final manuscript was read and approved by all three authors.